The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II trial of pharmacological ascorbate, gemcitabine, and nabpaclitaxel for metastatic pancreatic cancer.
 
Pashtoon Murtaza Kasi
Consulting or Advisory Role - Ipsen (Inst); Ipsen (Inst); Ipsen (Inst); Ipsen (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
Research Funding - Advanced Accelerator Applications (Inst); Advanced Accelerator Applications (Inst); Advanced Accelerator Applications (Inst); Advanced Accelerator Applications (Inst); Array BioPharma (Inst); Array BioPharma (Inst); Array BioPharma (Inst); Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst)
 
Kellie Bodeker
Research Funding - Advanced Accelerator Applications (Inst); Advanced Accelerator Applications (Inst); Advanced Accelerator Applications (Inst); Advanced Accelerator Applications (Inst); Galera Therapeutics (Inst); Galera Therapeutics (Inst); Galera Therapeutics (Inst); Galera Therapeutics (Inst); Infondrian (Inst); Infondrian (Inst); Infondrian (Inst); Infondrian (Inst); Ipsen (Inst); Ipsen (Inst); Ipsen (Inst); Ipsen (Inst); Progenics (Inst); Progenics (Inst); Progenics (Inst); Progenics (Inst); Soligenix (Inst); Soligenix (Inst); Soligenix (Inst); Soligenix (Inst)
 
Daniel James Berg
Research Funding - Array BioPharma (Inst); Array BioPharma (Inst); Array BioPharma (Inst); Array BioPharma (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Millennium (Inst); Millennium (Inst); Millennium (Inst); Millennium (Inst); Newlink Genetics (Inst); Newlink Genetics (Inst); Newlink Genetics (Inst); Newlink Genetics (Inst)
 
Chandrikha Chandrasekharan
No Relationships to Disclose
 
Saima Sharif
No Relationships to Disclose
 
Brian J. Smith
No Relationships to Disclose
 
Sandy-Vollstedt@uiowA.edu Vollstedt
No Relationships to Disclose
 
Heather Brown
Research Funding - Galera Therapeutics (Inst); Galera Therapeutics (Inst); Galera Therapeutics (Inst); Galera Therapeutics (Inst); Infondrian (Inst); Infondrian (Inst); Infondrian (Inst); Infondrian (Inst); Soligenix (Inst); Soligenix (Inst); Soligenix (Inst); Soligenix (Inst)
Travel, Accommodations, Expenses - Galera Therapeutics; Galera Therapeutics; Galera Therapeutics; Galera Therapeutics
 
Meghan Chandler
No Relationships to Disclose
 
Joseph J. Cullen
No Relationships to Disclose